The size of the European Diagnostic Catheter Market has been calculated at USD 0.96 Billion in 2022. It is forecasted to be growing at a CAGR of 7.1% and worth USD 1.36 Billion by 2027.
Catheters are thin tubes made of medical grade material such as plastic, silicon rubber, polyvinyl chloride (PVC), and nylon used for therapeutic and diagnostic purposes.
They are inserted into a patient’s body and are used along with many medical procedures like angioplasty, cardiac electrophysiology, and neurosurgery. The Europe Diagnostic Catheter Market is expected to witness moderate growth during the forecast period, owing to the rise in a number of surgeries and high demand for minimally invasive procedures. In addition, an increase in the geriatric population base and a rise in demand for sterile & disposable catheters supplement the market growth. Furthermore, an increase in reimbursement levels and advancements in catheter technology are expected to boost the market growth. However, inadequate quality assurance and price competition at domestic levels are expected to hamper this growth.
This research report on Europe Diagnostic Catheter Market has been segmented and sub-segmented into the following categories.
Geographically, the European region holds a considerable share in the global market and is expected to grow at a steady rate.
Companies playing a promising role in the European Diagnostic Catheter Market profiled in this report are Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (U.S.), Medtronic plc (Ireland), Johnson & Johnson (U.S.), Koninklijke Philips N.V. (Netherlands), B. Braun Melsungen AG (Germany), C.R. Bard, Inc. (U.S.), Cardinal Health, Inc. (U.S.), Edward Lifesciences Corporation (U.S.), and Terumo Corporation (Japan).
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com